Designed by UK podiatrists

Targeted pressure relief for corns and callus, in everyday shoes.

ZeroSole's silicone hexagon cells pull out by hand beneath the painful area, creating a custom offloading zone in seconds. Used across the NHS.

نعل ZeroSole Reliever القابل للتخصيص لتخفيف الضغط عن مسامير القدم والتقرنات

Why Kaydiar Medical

What sets Kaydiar Medical apart

Up to 32% less pressure

At the target area, without affecting gait (ATiC pressure mapping).

Clinically proven

Significant pain reduction over six weeks in a Cardiff Met study.

Modify in seconds

No scissors or equipment: perfect for busy clinics and home visits.

Fits everyday shoes

A low-profile insole with arch support and heel cup.

Kaydiar Medical is a UK company founded by podiatrists David Barton and Heather Smart. Its ZeroSole Reliever is a customisable offloading insole for corns, calluses, metatarsalgia, heel pain and other pressure-induced foot pain. ZeroSole is supplied through the NHS and professional podiatry wholesalers.

How ZeroSole works

ZeroSole has a grid of medical-grade silicone hexagon cells over a memory-foam mid-layer. To create a pressure-relief zone, you simply pull out the cells directly beneath the painful area, with no scissors or special equipment. This takes load away from the lesion, while the rest of the insole keeps cushioning the foot. It takes seconds to modify, so it is ideal for busy clinics and home visits.

  • Targeted offloading: removing cells reduces pressure at the target area by up to 32% compared with normal shoes
  • Full-length cushioning with a mild arch support and heel cup
  • Low profile: fits into everyday footwear, which helps patients keep wearing it
  • Durable: an integral silicone design that lasts at least 6 months
  • Two sizes: UK 4–7 (EU 37–41) and UK 8–11 (EU 42–46), with UK/EU/US trim lines printed on the insole

How to fit ZeroSole

The evidence

  • Laboratory pressure mapping (Assistive Technologies Innovation Centre, University of Wales Trinity Saint David, 2022): in 15 participants, ZeroSole with cells removed reduced mean pressure in the target zone by 23–32% compared with normal shoes, without affecting gait.
  • Clinical study (Cardiff Metropolitan University): over six weeks, patients with plantar corns and calluses had a statistically significant reduction in pain and a clinically noteworthy reduction in lesion size.

Patients with diabetic peripheral neuropathy should use ZeroSole only under the guidance of a healthcare professional.

Downloads

Shop ZeroSole

Want ZeroSole for your clinic or pharmacy? Contact the Qaadir team.

Supplied and supported by Qaadir

Talk to us about Kaydiar Medical

Get a quote, arrange a demo or ask about installation, training and equipment financing.

Qaadir logo

© 2026 Qaadir - Ability for All, مدعوم من Shopify